DRI Healthcare Trust Reports Second Quarter 2022 Results - Continued strong financial results and cash generation from existing assets - - Addition of pegcetacoplan to royalty portfolio subsequent to quarter end - TORONTO , Aug. 3, 2022 |CNW| - DRI Healthcare Trust (TSX: DHT ) (TSX: DHT ) ("DRI" or "the Trust") today announced its financial results for the quarter ended June 30, 2022. The Trust''s second quarter 2022 financial statements and Management''s Discussion Analysis ("MDA") have been filed on SEDAR ( www.sedar.com ). All dollar amounts are expressed in US dollars unless otherwise indicated. "The Trust had another successful quarter, with continued strong performance of our assets" said Behzad Khosrowshahi , Chief Executive Officer of DRI Healthcare Trust. "We are excited with the addition of pegcetacoplan to the portfolio, another high-quality asset with a long-term horizon and attractive growth prospects including through a number of pipeline indications. Our financial flexibility and robust pipeline put us in excellent position to continue sourcing and executing on attractive opportunities and deliver on the value proposition for our unitholders." Second Quarter Highlights Total Income of US$21.3 million